Search

Your search keyword '"McCarthy, SA"' showing total 184 results

Search Constraints

Start Over You searched for: Author "McCarthy, SA" Remove constraint Author: "McCarthy, SA"
184 results on '"McCarthy, SA"'

Search Results

1. SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2

2. Genomic reconstruction of the SARS-CoV-2 epidemic in England

3. The genome sequence of the European golden eagle, Aquila chrysaetos chrysaetos Linnaeus 1758.

4. The genome sequence of the eastern grey squirrel, Sciurus carolinensis Gmelin, 1788

5. The genome sequence of the Eurasian red squirrel, Sciurus vulgaris Linnaeus 1758

6. Common genetic variation drives molecular heterogeneity in human iPSCs

10. The genome sequence of the European turtle dove, Streptopelia turtur Linnaeus 1758

11. Genomic reconstruction of the SARS-CoV-2 epidemic in England

12. Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

13. SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2

14. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

15. The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis

16. Tracking SARS-CoV-2 mutations and variants through the COG-UK-Mutation Explorer

17. Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021

21. The European Reference Genome Atlas: piloting a decentralised approach to equitable biodiversity genomics.

22. Genomic changes and stabilization following homoploid hybrid speciation of the Oxford ragwort Senecio squalidus.

23. Prostate-specific antigen and health-related quality of life in individuals with advanced prostate cancer treated with apalutamide: a plain language summary of the SPARTAN and TITAN studies.

24. Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer.

25. Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapy.

26. Influential Factors Impacting Treatment Decision-making and Decision Regret in Patients with Localized or Locally Advanced Prostate Cancer: A Systematic Literature Review.

27. Perception of cure in prostate cancer: human-led and artificial intelligence-assisted landscape review and linguistic analysis of literature, social media and policy documents.

28. A chromosomal reference genome sequence for the malaria mosquito, Anopheles gambiae , Giles, 1902, Ifakara strain.

29. Prostate-specific antigen (PSA) decline with apalutamide therapy is associated with longer survival and improved outcomes in individuals with metastatic prostate cancer: a plain language summary of the TITAN study.

30. Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.

31. A chromosomal reference genome sequence for the malaria mosquito, Anopheles moucheti , Evans, 1925.

32. Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study.

33. MitoHiFi: a python pipeline for mitochondrial genome assembly from PacBio high fidelity reads.

34. Genomics of cold adaptations in the Antarctic notothenioid fish radiation.

35. Caecilian Genomes Reveal the Molecular Basis of Adaptation and Convergent Evolution of Limblessness in Snakes and Caecilians.

36. Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer.

37. Duration of Referral-to-Death and its Associated Factors Among Cancer and Noncancer Patients: Retrospective Cohort Study of a Community Palliative Care Setting in Malaysia.

38. YaHS: yet another Hi-C scaffolding tool.

39. Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer.

40. Tracking the randomized rollout of a Veterans Affairs opioid risk management tool: A multi-method implementation evaluation using the Consolidated Framework for Implementation Research (CFIR).

41. Radiographic progression-free survival in the ACIS trial for prostate cancer - Authors' reply.

43. Efficient iterative Hi-C scaffolder based on N-best neighbors.

44. Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study.

46. The complete genome sequence of Eimeria tenella (Tyzzer 1929), a common gut parasite of chickens.

47. The genome sequence of the European turtle dove, Streptopelia turtur Linnaeus 1758.

48. Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study.

49. The genome sequence of the European water vole, Arvicola amphibius Linnaeus 1758.

50. The genome sequence of the Norway rat, Rattus norvegicus Berkenhout 1769.

Catalog

Books, media, physical & digital resources